摘要
背景:智能纳米载体已被设计用于组织特异性靶向药物递送,持续或触发药物释放和协同药物组合的共递送以开发更安全和更有效的治疗剂。 目标:药物递送系统的进展可减少副作用,延长循环半衰期并改善药代动力学。 结果:在癌症的情况下,智能药物递送系统已经成功实现。通过考虑来自健康组织的肿瘤微环境的差异,诸如低pH值,低氧水平或基质金属蛋白酶的高酶活性,这些纳米载体可以用作智能系统。 结论:通过增强智能纳米载体的细胞内化和控制药物释放,改善了用于癌症诊断和治疗的抗癌剂的性能。在这里,我们回顾了定位,细胞内化;控制药物释放和智能药物输送系统的毒性。我们也强调智能纳米载体的刺激响应控制药物释放
关键词: 智能药物递送,刺激响应药物释放,纳米载体,靶向药物递送,智能纳米载体,靶向癌症治疗
图形摘要
Current Drug Targets
Title:Smart Drug Delivery Systems in Cancer Therapy
Volume: 19 Issue: 3
关键词: 智能药物递送,刺激响应药物释放,纳米载体,靶向药物递送,智能纳米载体,靶向癌症治疗
摘要: Background: Smart nanocarriers have been designed for tissue-specific targeted drug delivery, sustained or triggered drug release and co-delivery of synergistic drug combinations to develop safer and more efficient therapeutics.
Objective: Advances in drug delivery systems provide reduced side effects, longer circulation half-life and improved pharmacokinetics.
Results: Smart drug delivery systems have been achieved successfully in the case of cancer. These nanocarriers can serve as an intelligent system by considering the differences of tumor microenvironment from healthy tissue, such as low pH, low oxygen level, or high enzymatic activity of matrix metalloproteinases.
Conclusion: The performance of anti-cancer agents used in cancer diagnosis and therapy is improved by enhanced cellular internalization of smart nanocarriers and controlled drug release. Here, we review targeting, cellular internalization; controlled drug release and toxicity of smart drug delivery systems. We are also emphasizing the stimulus responsive controlled drug release from smart nanocarriers.
Export Options
About this article
Cite this article as:
Smart Drug Delivery Systems in Cancer Therapy, Current Drug Targets 2018; 19 (3) . https://dx.doi.org/10.2174/1389450117666160401124624
DOI https://dx.doi.org/10.2174/1389450117666160401124624 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
mTOR Targeted Cancer Chemoprevention by Flavonoids
Current Medicinal Chemistry Bioactivities of Iridoids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Applications of Lipid-based Nanocarriers for Parenteral Drug Delivery
Current Medicinal Chemistry Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
Current Alzheimer Research Novel Histone Deacetylase Inhibitors for the Treatment of Pediatric Brain Tumors
Central Nervous System Agents in Medicinal Chemistry On Mechanisms of Reactive Metabolite Formation from Drugs
Mini-Reviews in Medicinal Chemistry Sphingolipids in Genetic and Acquired Forms of Chronic Kidney Diseases
Current Medicinal Chemistry Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases
Protein & Peptide Letters STAT3 as a Central Regulator of Tumor Metastases
Current Molecular Medicine State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes
Current Medicinal Chemistry Synthesis and <i>in Vitro</i> Cytotoxicity Evaluation of Phenanthrene Linked 2,4- Thiazolidinediones as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Pharmacokinetics of Polymeric Micelles for Cancer Treatment
Current Drug Metabolism Oral Nano-Delivery Systems for Colon Targeting Therapy
Pharmaceutical Nanotechnology Non-steroidal Anti-Inflammatory Drugs and Melanoma
Current Pharmaceutical Design Molecular Targeting in Pancreatic Cancer
Reviews on Recent Clinical Trials Regulation of Cell Migration and Invasion by Specific Modules of uPA: Mechanistic Insights and Specific Inhibitors
Current Drug Targets Novel Nitro-Heterocycles Sugar and Indoles Candidates as Lead Structures Targeting HepG2 and A549 Cancer Cell Lines
Current Bioactive Compounds The Coordinated Role of CYP450 Enzymes and P-gp in Determining Cancer Resistance to Chemotherapy
Current Drug Metabolism A Simple and Sensitive LC-MS/MS Method for the Simultaneous Determination of Cyclophosphamide and Doxorubicin Concentrations in Human Plasma
Current Pharmaceutical Analysis PET Radiopharmaceuticals for Personalized Medicine
Current Drug Targets